BeiGene to Present at Upcoming Investor Conferences

Rhea-AI Summary

BeiGene has announced its participation in two investor conferences: the 6th Annual Cowen IO Next Virtual Conference on November 11 at 9:40 a.m. ET and the 13th Annual Jefferies Global Healthcare Conference on November 16 at 11:25 a.m. ET. A live webcast will be available on BeiGene's investor website, with an archived replay accessible for 90 days post-event. BeiGene is dedicated to developing affordable oncology medicines and operates globally with over 9,000 employees across multiple locations including Beijing, Cambridge, and Basel.

CAMBRIDGE, Mass. & BASEL, Switzerland & BEIJING--(BUSINESS WIRE)-- BeiGene (NASDAQ: BGNE; HKEX: 06160; SSE: 688235), a global biotechnology company, today announced that the Company will participate in two upcoming investor conferences:

• The 6^th Annual Cowen IO Next Virtual Conference on Friday, November 11, at 9:40 a.m. (ET); and
• The 13^th Annual Jefferies Global Healthcare Conference in London on Wednesday, November 16 at 11:25 a.m. (ET).

A live webcast can be accessed from the investors section of BeiGene’s websites at https://ir.beigene.com, https://hkexir.beigene.com and https://sseir.beigene.com. An archived replay will be available for 90 days following the event.

About BeiGene
BeiGene is a global biotechnology company that is developing and commercializing innovative and affordable oncology medicines to improve treatment outcomes and access for far more patients worldwide. With a broad portfolio, we are expediting development of our diverse pipeline of novel therapeutics through our internal capabilities and collaborations. We are committed to radically improving access to medicines for far more patients who need them. Our growing global team of more than 9,000 colleagues spans five continents, with administrative offices in Beijing, China; Cambridge, U.S.; and Basel, Switzerland. To learn more about BeiGene, please visit www.beigene.com and follow us on Twitter at @BeiGeneGlobal.

View source version on businesswire.com: https://www.businesswire.com/news/home/20221104005187/en/

Investor

Kevin Mannix

+1-857-302-5189

ir@beigene.com

Media

Kyle Blankenship

+1 667-351-5176

media@beigene.com

Source: BeiGene

FAQ

When will BeiGene participate in the Cowen IO Next Virtual Conference?

BeiGene will participate in the Cowen IO Next Virtual Conference on November 11 at 9:40 a.m. ET.

What is the date and time for BeiGene's appearance at the Jefferies Global Healthcare Conference?

BeiGene will present at the Jefferies Global Healthcare Conference on November 16 at 11:25 a.m. ET.

Where can I access the live webcast of BeiGene's investor conferences?

The live webcast can be accessed on BeiGene's investor website.

How long will the archived replay of the investor conferences be available?

The archived replay will be available for 90 days following the events.

What is BeiGene's focus in the biotechnology sector?

BeiGene focuses on developing innovative and affordable oncology medicines to improve patient access and treatment outcomes.